Interestingly, I bought at 2.64 and today's range has been 2.65-2.78. It didn't drop as low as my price yesterday, even though my price yesterday was in the middle of the day's range, too. Today the market has been vacillating between being down some and up some, a day in which a lot of stocks were down some and up some, too. So that suggests to me there's a bit of buying in ADCT right now, since it was more up than down.
I know you can't make a big case for this on the basis of one day's action, but I agree that the telecom industry is due for a break to the upside and like you, I think ADCT could do well in such an atmosphere.
Linda
I got shot off my horse. So what? I'm up again. Mark Knopfler
Recent ADCT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 08:06:52 PM
- ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/09/2024 11:15:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:07:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2024 08:06:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/07/2024 08:02:43 PM
- ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants • GlobeNewswire Inc. • 05/06/2024 11:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/06/2024 10:51:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 10:38:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:29:27 AM
- ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/06/2024 10:10:00 AM
- ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma • GlobeNewswire Inc. • 05/06/2024 10:00:00 AM
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024 • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma • GlobeNewswire Inc. • 04/04/2024 11:00:00 AM
- ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024 • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit • GlobeNewswire Inc. • 03/06/2024 12:15:00 PM
- ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/05/2024 10:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 02:15:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:37 PM
- ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 01:00:36 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM